Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    -0.11 (-8.40%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Device Authority Agreement with Avnet

22 Feb 2022 15:09

RNS Number : 4653C
Tern PLC
22 February 2022
 

REACH

 

22 February 2022

 

Tern Plc

("Tern" or the "Company")

 

Device Authority Agreement with Avnet

 

Tern Plc (AIM:TERN), the company focused on value creation from Internet of Things ("IoT") technology businesses, is pleased to note that Device Authority Limited ("Device Authority") has announced that it has entered into an agreement with Avnet, Inc. ("Avnet") to help customers worldwide manage and protect their connected device infrastructure.

 

Device Authority's existing relationship with Avnet (Nasdaq: AVT), a global technology distributor and solutions provider, has been deepened by the agreement entered into on 22 February 2022 to help customers worldwide manage and protect their connected device infrastructure through the combination of their technologies. Under the agreement, Avnet will integrate Device Authority's KeyScaler platform into its cloud-based device management platform, IoTConnect. This integration will allow device makers to secure and manage the full identity lifecycle of their devices through Avnet's IoTConnect Platform, which is designed to accelerate and scale IoT deployments worldwide.

 

As part of the agreement, Device Authority has joined Avnet's IoTConnect Partner Program with a shared goal to provide customers with seamless, industry leading IoT system designs on Avnet's IoTConnect Platform. Avnet's IoTConnect Partner Program is one part of Avnet's IoTConnect Solutions Suite.

 

Commenting, Lou Lutostanski, Vice President of IoT, Avnet, said: "Many IoT deployments lack built-in security to counter threats, so our industry-first solution securely manages IoT devices throughout the entire value chain, from chip manufacturer through device-makers, and to end customers across multiple sectors.

 

"By integrating device identity lifecycle management into Avnet's IoTConnect solution, we're enabling users to manage devices built on multiple different technologies and platforms through a single pane of glass. With that visibility and access to key features such as delivering and managing PKI (Public Key Infrastructure) certificates all in one platform, our customers can deploy a sustainable long-term IoT security strategy more confidently."

 

Commenting, Darron Antill, CEO, Device Authority, said: "The proliferation of IoT devices is growing at an accelerating rate. Device-based security must start with a strong identity and include recognition of the full lifecycle that those devices will experience from initial registration to end-of-life. Avnet's global reach, and the device management capabilities of their IoTConnect platform combined with our KeyScaler platform brings a new level of IoT security to our joint customers."

 

Agreement with BSI

 

Device Authority's agreement with Avnet follows Device Authority's recently announced partnership with BSI Group ("BSI"), the business improvement and standards company, to protect customers from cyber-attacks by providing trust for IoT devices. Device Authority's partnership with BSI is designed to extend BSI's cybersecurity capabilities in EMEA and North America to include identity access management for IoT for the first time.

 

The partnership follows BSI's recent renaming of its Cybersecurity and Information Resilience division (CSIR) to 'BSI Digital trust' to reflect the evolution of the security and resilience landscape. Device Authority's work with BSI will enable them to ensure that their client's connected devices, applications, and data are protected against potential security threats. The collaboration will provide organisations with best practice security solutions to protect and manage IoT devices throughout their lifetime.

 

Commenting Al Sisto, CEO of Tern, said:

 

"I am delighted with the continuing rapid progress that Device Authority is making. Following the strategic investment from Venafi in December 2021, we are very pleased to see Device Authority enter into further partnerships with some of the world's leading IoT technology companies to help provide significant benefits to their customers from integrating Device Authority's KeyScaler platform.

 

"These relationships will help Device Authority further grow its monthly recurring revenues through its subscription base and its modularised licence platform, KeyScaler. Device Authority also continues to gain industry cybersecurity analyst recognition and we were delighted to see that ABI Research* recently reported that they consider Device Authority as the current industry leader in their IoT device identity lifecycle management competitive assessment."

 

*https://www.abiresearch.com/market-research/product/7779608-iot-device-identity-lifecycle-management/

 

Enquiries

 

Tern Plc

Al Sisto (CEO)

Sarah Payne (CFO)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

David Worlidge / Alex Brearley (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAELLFLLLLBBBD
Date   Source Headline
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.